List of Excipients in API cyclobenzaprine hcl er
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing cyclobenzaprine hcl er
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Direct_Rx | CYCLOBENZAPRINE HCL ER | cyclobenzaprine hcl er | 72189-362 | DIETHYL PHTHALATE | |
| Direct_Rx | CYCLOBENZAPRINE HCL ER | cyclobenzaprine hcl er | 72189-362 | ETHYLCELLULOSE | |
| Direct_Rx | CYCLOBENZAPRINE HCL ER | cyclobenzaprine hcl er | 72189-362 | FD&C BLUE NO. 1 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for cyclobenzaprine hcl er
Excipient focus: D&C YELLOW NO. 10
cyclobenzaprine hcl er drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl er drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIETHYL PHTHALATE
cyclobenzaprine hcl er drug variants containing DIETHYL PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl er drug variants not containing DIETHYL PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
cyclobenzaprine hcl er drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl er drug variants not containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
cyclobenzaprine hcl er drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl er drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
cyclobenzaprine hcl er drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl er drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C GREEN NO. 3
cyclobenzaprine hcl er drug variants containing FD&C GREEN NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl er drug variants not containing FD&C GREEN NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
cyclobenzaprine hcl er drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl er drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
cyclobenzaprine hcl er drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl er drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
cyclobenzaprine hcl er drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl er drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
cyclobenzaprine hcl er drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl er drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
cyclobenzaprine hcl er drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl er drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
cyclobenzaprine hcl er drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl er drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
cyclobenzaprine hcl er drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl er drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
cyclobenzaprine hcl er drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl er drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
cyclobenzaprine hcl er drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | cyclobenzaprine hcl er | 72189-362 |
| Direct_Rx | cyclobenzaprine hcl er | 72189-389 |
| >Company | >Ingredient | >NDC |
cyclobenzaprine hcl er drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
